Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Odén

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
European Journal of Endocrinology|January 10, 2004
Persistent disease after surgery for primary hyperparathyroidism: the long-term outcomeGunilla Hedbäck, Anders Odén
European Journal of Endocrinology|March 27, 2003
Recurrence of hyperparathyroidism; a long-term follow-up after surgery for primary hyperparathyroidismGunilla Hedbäck, Anders Odén
Lakartidningen|November 15, 2008
[Provocation at the initiation of warfarin treatment]Anders Odén, Martin Fahlén
BMJ (Clinical Research Ed.)|November 9, 2002
Oral anticoagulation and risk of death: a medical record linkage studyAnders Odén, Martin Fahlén
Scandinavian Journal of Gastroenterology|June 3, 2009
Management of hepatic portal venous gas and pneumatosis intestinalis in critically sick adult patientsAmir Khorram-Manesh, Anders Odén
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 31, 2011
A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of SwedenCecilia Ahlgren, Anders Odén, Jan Lycke
Plos One|September 30, 2014
High nationwide incidence of multiple sclerosis in SwedenCecilia Ahlgren, Anders Odén, Jan Lycke
Thrombosis Research|March 7, 2006
Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisalAnders Odén, Martin Fahlén, Robert G Hart
Primary Care Diabetes|November 8, 2011
The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetesMarcus Lind, Martin Fahlén, Björn Eliasson, et al.
Journal of Neuroimmunology|April 14, 2012
Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndromeCecilia Ahlgren, Anders Odén, Tomas Bergström, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
European Journal of Endocrinology|January 10, 2004
Persistent disease after surgery for primary hyperparathyroidism: the long-term outcomeGunilla Hedbäck, Anders Odén
European Journal of Endocrinology|March 27, 2003
Recurrence of hyperparathyroidism; a long-term follow-up after surgery for primary hyperparathyroidismGunilla Hedbäck, Anders Odén
Lakartidningen|November 15, 2008
[Provocation at the initiation of warfarin treatment]Anders Odén, Martin Fahlén
BMJ (Clinical Research Ed.)|November 9, 2002
Oral anticoagulation and risk of death: a medical record linkage studyAnders Odén, Martin Fahlén
Scandinavian Journal of Gastroenterology|June 3, 2009
Management of hepatic portal venous gas and pneumatosis intestinalis in critically sick adult patientsAmir Khorram-Manesh, Anders Odén
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 31, 2011
A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of SwedenCecilia Ahlgren, Anders Odén, Jan Lycke
Plos One|September 30, 2014
High nationwide incidence of multiple sclerosis in SwedenCecilia Ahlgren, Anders Odén, Jan Lycke
Thrombosis Research|March 7, 2006
Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisalAnders Odén, Martin Fahlén, Robert G Hart
Primary Care Diabetes|November 8, 2011
The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetesMarcus Lind, Martin Fahlén, Björn Eliasson, et al.
Journal of Neuroimmunology|April 14, 2012
Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndromeCecilia Ahlgren, Anders Odén, Tomas Bergström, et al.
Pageof 9